# Lenalidomide for Adult Histiocyte Disorders

> clinical trial · VERIFIED · 2026-07-23

Status: ACTIVE_NOT_RECRUITING · Sponsor: Dana-Farber Cancer Institute · Condition: Langerhans Cell Histiocytosis (LCH)

- Company: Dana-Farber Cancer Institute
- Sector: Langerhans Cell Histiocytosis (LCH)
- Primary source: https://clinicaltrials.gov/study/NCT02523040

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.